- ICH GCP
- US Clinical Trials Registry
- Search trials
Søg i kliniske forsøg efter: Sintilimab og Lenvatinib
I alt 271934 resultater
-
Tianjin Medical University Cancer Institute and...RekrutteringSintilimab, Cetuximab, Regorafenib, Combine, mCRCKina
-
Shandong Cancer Hospital and InstituteRekruttering
-
jianming xuNeoCuraRekruttering
-
Shandong Cancer Hospital and InstituteIkke rekrutterer endnu
-
Sun Yat-sen UniversityRekrutteringGastrisk AdenocarcinomKina
-
Zhejiang Cancer HospitalAfsluttet
-
Fudan UniversityRekruttering
-
Henan Cancer HospitalRekrutteringMetastatisk Gastroøsofageal Junction AdenocarcinomaKina
-
Innovent Biologics (Suzhou) Co. Ltd.Afsluttet
-
Innovent Biologics (Suzhou) Co. Ltd.Afsluttet
-
West China HospitalSichuan Provincial People's Hospital; The First People's Hospital of Ziyang og andre samarbejdspartnereIkke rekrutterer endnu
-
Mian XIRekrutteringHepatocellulært karcinomKina
-
Sun Yat-sen UniversityRekrutteringEsophagogastric Junction AdenocarcinomKina
-
Tang-Du HospitalAfsluttetSintilimab og Anlotinib i kombination med kemoterapiKina
-
China Medical University, ChinaShengjing Hospital; The People's Hospital of Liaoning Province; The First... og andre samarbejdspartnereUkendt
-
Regina Elena Cancer InstituteUniversity of Pisa; University of Roma La Sapienza; University of Turin,... og andre samarbejdspartnereRekrutteringDifferentieret skjoldbruskkirtelkræft | KønItalien
-
Immunovative Therapies, Ltd.Mirror Biologics, Inc.Rekruttering
-
Shanghai Zhongshan HospitalAktiv, ikke rekrutterendeCholangiocarcinom, intrahepatiskKina
-
National University Hospital, SingaporeEisai Co., Ltd.; Tan Tock Seng HospitalUkendt
-
Tianjin Medical University Second HospitalRekruttering
-
HutchmedRekrutteringAvanceret solid tumorKina
-
The First Affiliated Hospital of Soochow UniversityInnovent Biologics (Suzhou) Co. Ltd.Rekruttering
-
Innovent Biologics (Suzhou) Co. Ltd.Ikke rekrutterer endnu
-
The First Hospital of Jilin UniversityAktiv, ikke rekrutterendeIIIA Stadium ikke-småcellet lungekræftKina
-
Innovent Biologics (Suzhou) Co. Ltd.AfsluttetAvancerede solide tumorerKina
-
Henan Cancer HospitalUkendtSmåcellet lungekræft | Kemoterapi | Adoptiv cellulær immunterapi | Vedligeholdelse | Omfattende sygdomKina
-
Peking Union Medical College HospitalSun Yat-Sen Memorial Hospital of Sun Yat-Sen University; The Second Affiliated...RekrutteringTilbagevendende ovariekarcinomKina
-
Massachusetts Eye and Ear InfirmaryEisai Inc.RekrutteringAvanceret kræft | Differentieret skjoldbruskkirtelkræftForenede Stater
-
Peking Union Medical College HospitalAfsluttetCholangiocarcinom | Biomarkør | Kombination af immunterapi | Lever Neoplasma Malign PrimærKina
-
Tianjin Medical University Cancer Institute and...RekrutteringGastrisk neuroendokrint karcinomKina
-
Fudan UniversityRekrutteringHepatocellulært karcinomKina
-
Fudan UniversityAfsluttetHepatocellulært karcinomKina
-
Hebei Medical University Fourth HospitalRekruttering
-
Fudan UniversityRekruttering
-
Qilu Pharmaceutical Co., Ltd.Ikke rekrutterer endnuAvanceret nyrecellekarcinom
-
Hunan Province Tumor HospitalRekruttering
-
Tianjin Medical University Cancer Institute and...Ikke rekrutterer endnuResektabelt hepatocellulært karcinomKina
-
Yunfei YuanRekrutteringHepatocellulært karcinom | Transarteriel kemoemboliseringKina
-
West China HospitalIkke rekrutterer endnu
-
Shanghai Zhongshan HospitalSun Yat-sen University; Eastern Hepatobiliary Surgery HospitalIkke rekrutterer endnuHepatocellulært karcinomKina
-
Zhejiang Cancer HospitalIkke rekrutterer endnuSmåcellet lungekræft omfattende stadie
-
Tianjin Medical University Cancer Institute and...Ikke rekrutterer endnuResektabelt hepatocellulært karcinom
-
AkesoAkeso Pharmaceuticals, Inc.Afsluttet
-
Fudan UniversityInnovent Biologics (Suzhou) Co. Ltd.Ikke rekrutterer endnuEsophageal pladecellekarcinomKina
-
Peking Union Medical College HospitalHarbin Medical University; The First Affiliated Hospital of Xiamen UniversityRekrutteringNeuroendokrine tumorer | Neuroendokrint karcinom | Neuroendokrin neoplasma | Neuroendokrin tumor grad 3Kina
-
Fudan UniversityRekruttering
-
Shanghai Pulmonary Hospital, Shanghai, ChinaRekrutteringIkke-småcellet lungekræft stadie IIIKina
-
Peking Union Medical College HospitalRekruttering
-
Sichuan UniversityIkke rekrutterer endnuCarrelizumab Plus Lenvatinib kombineret med TACE | Borderline resektabelt hepatocellulært karcinomKina
-
Assistance Publique - Hôpitaux de ParisEisai Inc.Aktiv, ikke rekrutterendeNeoadjuverende og adjuverende lenvatinib hos HCC-patienter behandlet med perkutan ablativ (LENVABLA)Hepatocellulært karcinomFrankrig